Abnormal regulation of placental apoptosis and proliferation has been implicated in placental disorders. Recently, several DNA-damaging agents were reported to induce excessive apoptosis and reduce cell proliferation in the placenta; however, the molecular pathways of these toxic effects on the placenta are unclear. The aim of the present study was to determine the involvement of TRP53, a tumor suppressor that mediates cellular responses to DNA damage, in the induction of apoptosis and cell cycle arrest in the developing placenta. For this purpose, we treated pregnant mice on Day 12 of gestation with 10 mg/kg of etoposide and 5-Gy gamma irradiation, potent inducers of DNA damage. We found an increase in the number of trophoblastic apoptoses 8 and 24 h after etoposide injection and 6 and 24 h after irradiation in the placental labyrinth zone. The number of mitoses and DNA syntheses in trophoblasts decreased after treatment. The accumulation and phosphorylation of TRP53 protein were detected 8 and 6 h after etoposide injection and irradiation, respectively. In Trp53-deficient placentas, the induction of etoposide-induced trophoblastic apoptosis is abrogated, while the reduction of proliferation occurred similarly as in wild-type placentas. CDC2A, a regulator of G2/M progression, was inactivated by phosphorylation after etoposide injection and irradiation, suggesting that the cell cycle was arrested at the G2/M border by treatment. Our study demonstrated that etoposide injection induced TRP53-dependent apoptosis and TRP53-independent cell cycle arrest in labyrinthine trophoblasts, providing insights into the molecular pathway of placental disorders.
INTRODUCTION
DNA damage such as that caused by radiation and chemotherapeutic agents potently inhibits fetal growth and induces congenital anomalies [1, 2] . DNA damage provokes apoptosis in fetal tissues, and these effects are believed to be a major cause of fetotoxicity such as congenital anomalies and fetal death. Recently, several DNA-damaging agents have been reported to induce excessive apoptosis and impair proliferation in the placenta. A DNA-alkylating agent, ethylnitrosourea [3] , and an inhibitor of DNA replication, cytosine arabinoside [4, 5] , provoked trophoblastic apoptosis and suppressed cell proliferation in the placental labyrinth zone. A DNAdemethylating agent, 5-azacytidine, was reported to suppress placental proliferation and growth [6] . It is thought that abnormal regulation of trophoblastic apoptosis contributes to the progression of pathological processes in the placenta [7] [8] [9] [10] [11] . Thus, it is likely that DNA damage impairs placental function and development through the induction of apoptosis.
The tumor suppressor TRP53 serves as a critical regulator of apoptosis and cell cycle arrest after various types of cellular stress, including DNA damage [12] [13] [14] [15] [16] . In response to DNA damage, TRP53 protein is stabilized and activated by phosphorylation of its specific residues to increase the transcription of TRP53 target genes. These genes are involved in apoptosis, cell cycle arrest, and DNA repair. Some proapoptotic BCL2 family members such as Bax, Bbc3 (puma), and Pmaip1 (noxa) are transcriptional targets of TRP53 [14] . Products of these genes lead to the release of mitochondrial cytochrome c into the cytosol, which in turn activates caspase 9 (CASP9), an initiator caspase. Activated CASP9 further provokes activation of CASP3, the key inducers of apoptosis [17] . We previously reported that cytosine arabinoside induces TRP53-dependent trophoblastic apoptosis concomitant with the upregulation of TRP53 target gene expression [5] .
In the presence of DNA damage, cell cycle checkpoint machinery actively halts progression through the cell cycle at the G1 or S phase or G2/M border [18] [19] [20] . This enables cells to promote DNA repair or, in the case of irreparable DNA damage, to eliminate the damaged cells by apoptosis. In checkpoint machinery, DNA damage sensor proteins monitor abnormal chromosome structures and then activate DNA damage transducer proteins, which suppress the function of cell cycle promoters such as cyclins and cyclin-dependent kinases (CDKs). These transducer proteins regulate cell cycle progression by directly affecting cell cycle promoters and by activating TRP53 protein; thus, cell cycle arrest can occur in a TRP53-dependent and/or -independent manner.
Etoposide, a chemotherapeutic agent, and irradiation are known to induce DNA double-strand breaks [21, 22] . Treatment with etoposide or irradiation to pregnant animals induces fetal cell apoptosis, fetal growth retardation, congenital anomalies, and fetal death [23] [24] [25] [26] [27] [28] ; however, effects of these treatments on the placenta are unknown, especially in vivo. In the present study, we treated pregnant mice with etoposide or gamma irradiation and examined the changes in apoptosis and cell proliferation in the placental labyrinth zone. Moreover, to determine the involvement of TRP53 in these changes, we analyzed the expression and phosphorylation of TRP53 protein following treatment and examined the effects of etoposide injection on Trp53-deficient placentas. The levels of apoptosisand cell cycle-related proteins are also analyzed.
MATERIALS AND METHODS
The study protocol was approved by the Animal Care and Use Committee of the Graduate School of Agricultural and Life Sciences, The University of Tokyo. It was also approved by the Institutional Committee for Animal Safety and Welfare of the National Institute of Radiological Sciences.
Animals
Pregnant C57BL/6 mice were obtained from Japan SLC (Shizuoka, Japan). Heterozygous Trp53 gene-disrupted mice (C57BL-Trp53 þ/tm1Sia ; accession number CDB 0001K) were provided by RIKEN BRC (Tsukuba, Japan) [29] . Endogenous and disrupted Trp53 genes in each placenta were detected by PCR-based analysis of fetal tail DNA extracts. The morning on which a vaginal plug was seen was designated as Day 0 of gestation (GD0).
Chemicals and Irradiation
Etoposide (Cat. E1383; Sigma, St. Louis, MO) was dissolved in 1% dimethyl sulfoxide (DMSO) solution in physiological saline and adjusted to a concentration of 0.5 mg/ml. Bromodeoxyuridine (BrdU, Cat. B9285; Sigma) was dissolved in physiological saline and adjusted to a concentration of 1 mg/ ml. Exposure to 137 Cs-generated gamma ray was conducted with a Gammacell (Nordion, Ottawa, ON), and the mean dose rate was 0.65 Gy/min.
Treatments
Twelve pregnant mice were injected i.p. with 10 mg/kg of etoposide on GD12. Six pregnant animals were whole-body irradiated with 5-Gy gamma ray on GD12. Three animals were euthanized 1.5, 3, 8, and 24 h after etoposide treatment and 6 and 24 h after irradiation. As controls, six pregnant mice were injected i.p. with 1% DMSO solution in physiological saline on GD12, and three animals were euthanized 6 and 24 h after the injection.
For experiments using Trp53-disrupted mice, 10 female heterozygous (Trp53 þ/-) mice were mated with Trp53 þ/-males to generate wild-type (Trp53
, and homozygous gene-disrupted (Trp53 -/-) placentas. Six and four pregnant mice were injected with etoposide and vehicle, respectively, on GD12, and the placentas were collected 8 h after the treatment.
For histological analyses, placentas were fixed in 10% neutral buffered formalin, embedded in paraffin, and cut into 4-lm sections. The sections were stained with hematoxylin-eosin (HE). For Western blot analyses, one or two randomly chosen placentas were harvested and immediately dissected to remove the deciduas and stored at À808C.
Detection of Fragmented DNA
Apoptotic cells with fragmented DNA were detected by the TUNEL method with an Apop Tag peroxidase in situ apoptosis detection kit (Cat. S7100; Chemicon, Temecula, CA) in accord with the manufacturer's instructions. In brief, the procedure was as follows: sections were treated with 0.002% proteinase K (Wako, Osaka, Japan) for 15 min and then placed in 3% H 2 O 2 for 5 min. Multiple fragmented DNA 3 0 -OH ends on the sections were labeled with digoxigenin-deoxyuridine triphosphate in the presence of terminal deoxynucleotidyl transferase. Peroxidase-conjugated antidigoxigenin antibody was then reacted with the sections. Positive signals were visualized with a peroxidase-diaminobenzidine (DAB) reaction, and nuclei were counterstained with methyl green (DAKO, Carpinteria, CA).
Immunohistochemical Staining
For immunohistochemical staining, paraffin sections were deparaffinized and heated at 1218C for 15 min in 10 mM citrate buffer (pH 6.0) by autoclaving. The sections were then placed in 0.3% H 2 O 2 for 30 min and blocked in 8% skimmed milk for 1 h. Immunohistochemical staining for CDKN1A (p21 WAF1/CIP1 , 1:200, Cat. 556430; Pharmingen, San Diego, CA) and TRP53 (1:300, Cat. sc-6243; Santa Cruz Biotechnology, Santa Cruz, CA) was performed using the Envisionþ Kit (DAKO). The labeled streptavidin biotin (LSAB) method was used in immunohistochemical staining for histone H3 phosphorylated at serine 10 (1:200, Cat. 9701; Cell Signaling Technology, Beverly, MA), an M-phase marker, and for histone H2AFX (H2A.X) phosphorylated at serine 139 (1:200, Cat. 2577; Cell Signaling Technology). Primary antibodies were detected by biotin-labeled secondary antibodies (KPL, Gaithersburg, MD) and amplified with peroxidase-conjugated streptavidin (DAKO). Immunohistochemical staining for cleaved (activated) CASP3 (1:400, Cat. 9661; Cell Signaling Technology) was performed using the TSA biotin system (Perkin-Elmer, Boston, MA) in accord with the manufacturer's instructions. Positive signals were visualized with a peroxidase-DAB reaction, and nuclei were counterstained with methyl green.
BrdU Incorporation Assay
To detect DNA-replicating cells by histopathology, a BrdU incorporation assay was performed. Six pregnant mice were injected i.p. with 10 mg/kg of etoposide on GD12. Three animals were euthanized 3 and 8 h after etoposide treatment. As controls, three pregnant mice were injected i.p. with 1% DMSO solution in physiological saline on GD12 and euthanized 8 h after injection. All dams used in this assay were injected i.p. with 20 mg/kg of BrdU exactly 1 h before placenta collection. For immunohistochemical detection of BrdU, paraffin sections of placentas were prepared as already described. The sections were treated with 0.1% trypsin and 0.1% calcium chloride in Tris buffer at 378C for 30 min and then with 1 N HCl for 45 min, followed by incubation in 0.3% H 2 O 2 and next in 8% skimmed milk. After incubation with the primary antibody for BrdU (1:100, Cat. M0744; DAKO), the LSAB method was performed as already described.
Morphometry
For morphometry of TUNEL staining and immunostaining for phosphorylated histone H3, BrdU, and CDKN1A, four placentas were randomly chosen from one dam. In each placenta, 600 trophoblastic nuclei in the labyrinth zone were examined under a light microscope (4003 magnification). TUNEL, mitotic, BrdU-labeling, and CDKN1A-labeling indices were calculated as a percentage of positively stained trophoblastic nuclei among the total trophoblastic nuclei examined. For evaluation of the mitotic index, mitotic figures positively immunostained for phosphorylated histone H3 were counted as positive nuclei. To examine 600 nuclei, two or three microscopic fields were selected in each placenta. First, two fields located at one-third diameter from laterals of the labyrinth zone were selected. Then, if the number of nuclei counted in the fields did not reach 600, a field close to the central portion was also examined. Nuclei of two types of labyrinthine trophoblasts (cytotrophoblast and syncytiotrophoblast) were counted without distinction. The indices are expressed as the mean 6 SD of three dams for each experimental group. Statistical analysis was performed by one-way ANOVA, with the TukeyKramer multiple comparisons test. Earlier (1.5, 3, 6, and 8 h after the treatments) and later (24 h after the treatments) experimental groups were analyzed separately.
For experiments in Trp53-disrupted mice, all placentas from each dam were examined to count TUNEL, mitotic, and CDKN1A-labeling indices, and then following genotyping of the placentas, the indices of each genotype were expressed as the mean 6 SD of at least three dams. Statistical analysis was performed by two-way ANOVA, with the Tukey-Kramer multiple comparisons test.
Sample Preparation for Western Blot Analysis
The placentas were homogenized in 10 mM Tris-HCl buffer (pH 7.8) containing 150 mM NaCl, 1 mM edetic acid, 1% NP-40, 10 mM NaF, 2 mM Na 3 VO 4 , and proteinase inhibitor cocktail (Roche Applied Science, Penzberg, Germany) and used as a whole-cell lysate. Protein concentrations were determined with a Lowry protein assay kit (Bio-Rad, Hercules, CA).
Western Blot Analysis
Equal amounts of protein were loaded onto an SDS-PAGE gel, electrophoresed, and transferred to a polyvinylidene fluoride membrane (BioRad). After blocking with 5% skimmed milk or 5% bovine serum albumin, membranes were probed with antibodies to BAX (1:1000, Cat. 2772; Cell Signaling Technology), BBC3 (PUMA, 1:1000, Cat. P4618; Sigma), CASP9 For quantification of Western blot analyses, immunoreactive bands were quantified by densitometry using Quantity One software (Bio-Rad), and the expression levels were calculated relative to the levels of ACTB. For quantification of phosphorylated TRP53 and phosphorylated CDC2A, first the levels of total and phosphorylated proteins were calculated relative to those of ACTB, and then the levels of phosphorylated proteins were calculated against those of total protein. Fold changes, calculated relative to the values in the control groups 6 h after treatment, are shown as the mean 6 SD of two independent animals from each experimental group.
RESULTS

Etoposide-Induced Phosphorylation of Histone H2AFX
We first examined the induction of DNA double-strand breaks in etoposide-injected placentas. This was evaluated by detecting the phosphorylation of histone H2AFX at serine 139, a marker for the existence of DNA double-strand breaks [30] .
In immunohistochemistry for control placentas, positive signals were observed only in the nuclei of cytotrophoblasts in the labyrinth zone (Fig. 1A) . At 1.5 h after the etoposide injection to pregnant mice, positive signals were widely detected in the nuclei of syncytiotrophoblasts and in cytotrophoblasts. In Western blot analysis, the level of phosphorylated histone H2AFX increased 1.5 h after etoposide injection (Fig. 1B) .
Etoposide-and Gamma Ray-Induced Apoptosis in Labyrinthine Trophoblasts
The TUNEL index in the placental labyrinth zone significantly increased 8 and 24 h after etoposide injection compared with controls (Fig. 2) . A significant increase in the TUNEL index was also observed 6 and 24 h after irradiation. TUNEL-positive signals were observed mainly in trophoblastic nuclei (Fig. 2B) . Only a few TUNEL-positive nuclei were observed in the placental labyrinth zone in control dams throughout the experimental period.
In the placental junctional zone, a few TUNEL-positive signals were observed in control groups. The number was not changed by treatment with etoposide injection or irradiation (data not shown).
In immunohistochemistry for cleaved CASP3, many positive signals were detected in labyrinth zone three 8 h after etoposide injection and 6 h after irradiation (Fig. 3, B-D) . These signals were observed in the nuclei or cytosol of trophoblasts. Few positive signals were observed in the placental labyrinth zone of control animals (Fig. 3A) .
In HE staining, morphological features of apoptosis were seen. Margination and fragmentation of condensed chromatin (Fig. 3 , E and G) and apoptotic bodies (Fig. 3F) were observed in labyrinthine trophoblasts 8 and 6 h after etoposide injection and irradiation, respectively.
Etoposide-and Gamma Ray-Induced Cell Cycle Arrest in Labyrinthine Trophoblasts
In control placentas, many mitotic figures positively immunostained for phosphorylated histone HIST3 were observed. The mitotic index was significantly reduced 3, 8, and 24 h after etoposide injection and 6 h after irradiation compared with controls (Fig. 4) .
In the BrdU incorporation assay, the BrdU-labeling index was significantly reduced 3 and 8 h after etoposide treatment compared with the control group. Moreover, the staining intensity of each positive signal was also reduced in etoposidetreated placentas (Fig. 5 ).
Accumulation and Phosphorylation of TRP53 Protein in Etoposide-Treated and Irradiated Placentas
Immunohistochemical analysis of the placentas revealed that TRP53 protein accumulated in trophoblastic nuclei 8 and 6 h after etoposide injection and irradiation, respectively (Fig.  6A) . Upregulation of TRP53 protein after treatment was also detected by Western blot analysis (Fig. 6B) . In Trp53 -/-placentas, positive signals were not detected in immunohisto- chemistry for TRP53. Western blot analysis revealed that levels of TRP53 phosphorylated at serine 15 increased substantially 8 and 6 h after etoposide injection and irradiation, respectively (Fig. 6B) .
Role of TRP53 in Trophoblastic Apoptosis and Cell Cycle Arrest Following Etoposide Treatment
In Trp53 þ/þ and Trp53 þ/-placentas, the TUNEL index significantly increased after etoposide treatment compared with the control (vehicle treated) group of each genotype (Fig. 7) . In Trp53 -/-placentas, the TUNEL index did not change significantly in the etoposide-treated group compared with the control group. In contrast, mitotic indices in etoposidetreated groups significantly decreased compared with control groups in all genotypes (Fig. 8) .
Altered Expression of Apoptosis-Related Proteins Following Treatment with Etoposide and Irradiation
Protein levels of proapoptotic members of the BCL2 family [14] were examined by Western blot. The level of BAX increased slightly 6 h after etoposide injection. The level of BBC3 also increased slightly 8 and 6 h after etoposide injection and irradiation, respectively. The level of PMAIP1 hardly changed following treatment (Fig. 9) .
On apoptotic stimulation, CASP9 is cleaved into several active fragments [17] . The level of 37 M r 3 10 À3 of cleaved CASP9 increased markedly 6 h after irradiation. The level of 39 M r 3 10 À3 of cleaved CASP9 increased slightly 8 h after etoposide injection (Fig. 10 ). 
Accumulation of CDKN1A Protein in Etoposide-Treated and Irradiated Placentas
The production of CDKN1A, an inhibitor of CDKs, is controlled by TRP53 through transcriptional activation [31] . Immunohistochemical study revealed that CDKN1A protein accumulated in trophoblastic nuclei after etoposide injection and irradiation in Trp53 þ/þ placentas (Fig. 11A) . In Trp53
and Trp53 þ/-placentas, the CDKN1A-labeling index significantly increased after etoposide treatment compared with the control (vehicle treated) group of each genotype (Fig. 11B) . In Trp53 -/-placentas, the CDKN1A-labeling index did not change significantly in the etoposide-treated group compared with the control group. Western blot analysis also revealed that the level of CDKN1A protein increased markedly 8 and 6 h after etoposide injection and irradiation, respectively, in Trp53 þ/þ placentas (Fig. 11C ).
Altered Expression of Cell Cycle-Related Proteins Following Treatment with Etoposide and Irradiation
The level of CCNB1 substantially increased 8 and 6 h after etoposide injection and irradiation, respectively (Fig. 12A) . The level of CCND1 slightly decreased 6 h after irradiation, and the level of CCNE1 hardly changed following treatment.
CDC2A, a CDK, is essential for cell cycle progression into mitosis and is inactivated when phosphorylated at tyrosine 15 and threonine 14 [32] . Western blot analysis revealed that phosphorylation of CDC2A at tyrosine 15 was upregulated following etoposide injection and irradiation (Fig. 12B) .
DISCUSSION
We herein demonstrated that etoposide injection and irradiation to pregnant mice induced apoptosis and reduced proliferation in the placental labyrinth zone. Induction of apoptosis was further confirmed by the observation of cleavage of CASP3 and chromatin condensation and fragmentation in trophoblastic nuclei and apoptotic bodies, biochemical and morphological features of apoptosis. It is thought that cytotoxic effects of etoposide and irradiation are mediated mainly by DNA-damaging actions. Etoposide and irradiation are wellknown inducers of DNA double-strand breaks, highly toxic types of DNA damage. Etoposide interferes with topoisomerase II activity and causes DNA double-strand breaks by the formation of a cleavage complex containing DNA drug enzyme [21] . Ionizing radiation, including gamma ray, produces oxygen free radicals such as hydroxyl and superoxide radicals, which can inflict oxidative damage on DNA resulting in DNA double-strand breaks [22] . Although cells can adapt to low levels of irreparable DNA damage, one DNA double-strand break can be sufficient to induce cell death in some cases [33] .
In the present study, we determined whether etoposide treatment to pregnant mice provoked DNA double-strand breaks in the placenta. Histone H2AFX, a member of the histone H2A family, specifically controls the recruitment of 
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DNA repair proteins to sites of DNA damage [30] . Phosphorylation of this protein is considered a sensitive and specific marker of the existence of DNA double-strand breaks. By detecting the phosphorylation of histone H2AFX, we showed that etoposide injection into pregnant mice induced DNA double-strand beaks in trophoblasts in the placental labyrinth zone.
The phosphorylation of H2AFX at serine 139 is induced not only by primary DNA double-strand breaks but also by DNA fragmentation during apoptosis [34] . Thus, we examined the phosphorylation of histone H2AFX 1.5 h after etoposide injection, when an increase in the number of TUNEL-positive nuclei was not observed in the placenta. The rapid appearance of phosphorylated histone H2AFX in the present study indicated that phosphorylation was induced by etoposideinduced DNA double-strand breaks, not by apoptotic DNA fragmentation.
We found that histone H2AFX is phosphorylated in cytotrophoblasts even in control placentas. This may reflect the existence of physiological cellular stresses in labyrinthine cytotrophoblasts. In normal human pregnancy, naturally occurring stresses such as hypoxia and reactive oxygen species are considered to regulate trophoblastic cell fate, including proliferation, differentiation, and apoptosis [7, 8] . Because hypoxia and reactive oxygen species can break DNA strands and induce the phosphorylation of histone H2AFX [30, 35] , our observation suggests that such physiological stresses exist in murine cytotrophoblasts; however, because the process of trophoblastic turnover has not been well studied in rodents, the precise role of phosphorylated histone H2AFX in cytotrophoblasts is still to be clarified.
By inducing excessive apoptosis and reducing proliferation in the labyrinth zone, etoposide and irradiation treatment affected the development and function of the placenta. A number of placental structural and cellular abnormalities have been associated with pregnancy disorders [36, 37] . In particular, increased apoptosis of placental cells is considered a notable event responsible for abnormal function of the placenta. In human pregnancy, apoptosis is increased in placentas subjected to intrauterine growth retardation or other disorders [8] [9] [10] [11] 38] . In mice and rats, several developmental toxicants induce excessive placental apoptosis and impaired fetal growth [3, 4, [39] [40] [41] . Impaired proliferation of placental cells also potentially halts placental function because the establishment and turnover of the placenta involve intense proliferative activity of trophoblasts [7, 8, 42] . Treatment of pregnant animals with etoposide or irradiation was reported to induce fetal cell apoptosis and abnormal fetal growth [23] [24] [25] [26] [27] [28] . The results of the present study suggest that etoposide injection and irradiation affect fetal growth not only by damaging fetal cells but also by impairing placental development and function by the induction of apoptosis and cell cycle arrest in trophoblasts.
The findings in this study demonstrated that TRP53 is activated following etoposide injection and irradiation and showed that TRP53 is necessary for etoposide-induced trophoblastic apoptosis. Our Western blot examination revealed phosphorylation of TRP53 protein at serine 15 after etoposide injection and irradiation. Phosphorylation of the serine 15 residue is thought to induce stabilization of TRP53 protein by inhibiting MDM2-mediated degradation of TRP53 protein, leading to onset of TRP53 function as a transcription factor [13, 15] . Indeed, concomitant with TRP53 phosphorylation, accumulation of TRP53 protein was detected in our immunohistochemical and Western blot analyses. Moreover, TRP53-dependent accumulation of CDKN1A protein was observed in etoposide-treated placentas. Cdkn1a is a transcriptional target of TRP53 [31] , and our findings indicated that TRP53 is activated as a transcription factor. Finally, we demonstrated that etoposide-induced trophoblastic apoptosis is abrogated in Trp53 -/-placentas. Overall, our data suggested that TRP53 is activated in response to etoposide injection and irradiation and showed that TRP53 is essential for etoposideinduced trophoblastic apoptosis. Increased production of TRP53 protein is implicated as a cause of excessive apoptosis in human abnormal pregnancies [43, 44] , and our results further support the possibility that TRP53 is a mediator of trophoblastic apoptosis in placental disorders.
In the present study, we sought to clarify the molecular pathway of TRP53-dependent apoptosis induced by etoposide injection and irradiation by examining the levels of proapoptotic proteins. Apoptosis occurs through the mitochondrial or death receptor-mediated pathway, and the mitochondrial pathway is thought to be a major mechanism of DNA damage-induced TRP53-dependent apoptosis [12] [13] [14] . In this apoptotic pathway, increased expression of TRP53 target genes such as Bax, Bbc3, and Pmaip1 leads to mitochondrial cytochrome c release into cytosol and activation of CASP9. Our Western blot analysis detected a markedly increased protein level of cleaved CASP9 following irradiation, suggesting activation of the mitochondrial apoptotic pathway. In addition, increased protein levels of BAX and BBC3 were detected after etoposide injection and irradiation; however, the changes were slight. The increase in cleaved CASP9 level after etoposide injection was also very slight. Although involvement of the mitochondrial pathway is suspected, the molecular pathway of etoposide-and irradiation-induced trophoblastic apoptosis is still obscure. In addition, 24 h after etoposide injection and irradiation, induction of apoptosis was still observed, while TRP53 protein neither increased nor was phosphorylated. Regulators of apoptosis induction 24 h after treatment also remain to be determined. Further studies such as quantification of BCL2 family protein levels in the mitochondrial fraction would be helpful to clarify these remaining questions.
Reduction of proliferation occurred similarly in Trp53 -/-and Trp53 þ/þ placentas. Thus, in contrast to etoposide-induced trophoblastic apoptosis, TRP53 is not required for cell cycle arrest in trophoblasts. Western blot and immunohistochemical analyses detected an accumulation of CDKN1A protein after etoposide injection and irradiation. Because CDKN1A inhibits the function of CCNE1/CDK2 and CCND1/CDK4 complexes to block G1/S transition [31] , accumulation of CDKN1A in the placenta should have a role in etoposide-and irradiationinduced cell cycle arrest; however, etoposide-induced cell cycle arrest was observed even in Trp53 -/-placentas, in which CDKN1A accumulation was not detected. Thus, the precise role of CDKN1A accumulation is still unclear in this study.
What is the mechanism of cell cycle arrest following etoposide treatment? To clarify this point, we examined levels of cyclins and CDC2A. Cell cycle progression requires the precise replication of genomic DNA once during each cycle, and all events in the cell cycle have to occur in order. Cyclins and CDKs are key regulators in this reproductive process [45] . Cyclins undergo a cycle of protein synthesis and degradation at specific stages of the cell cycle. Cyclins bind and activate CDKs, which results in further activation of downstream proteins necessary for cell cycle progress. CCND1, the level of which is controlled largely by the extracellular environment (such as the presence of mitogens), allows cells to enter the S phase. CCNE1 is also required for S-phase initiation, and its level peaked at the G1/S border. CCNB1, which is necessary for mitosis initiation, accumulates as cells approach the M FIG. 12. A) Western blot analysis and protein expression levels of cyclins. B) Western blot analysis of total CDC2A and CDC2A phosphorylated at tyrosine 15 and total CDC2A. In A and B, data in the graph represent fold changes, calculated relative to the values in the control groups 6 h after treatment, and are shown as the mean 6 SD of two independent animals from each experimental group. Cont, control; Eto, etoposide; IR, irradiation. 820 phase and is abruptly degraded in metaphase during mitosis. In proliferating mammalian cells, the cell cycle completes within 10-24 h, and DNA synthesis requires at least 5 h [46] ; therefore, it is likely that alterations in BrdU-labeling and mitotic indices and cyclin levels from 3 to 8 h after etoposide injection and irradiation reflected the primary changes of cell cycle progression caused by treatment.
In the present study, several findings suggested that etoposide injection and irradiation blocked cell cycle progression at the G2/M border in trophoblasts. First, despite the rapid decrease in the mitotic index following treatment, the protein level of CCNB1, which normally peaks at the G2/M border to promote mitosis initiation, was markedly upregulated in the placenta. These observations imply that the cell cycle progressed to the G2/M border but did not enter mitosis. Second, phosphorylation of CDC2A at tyrosine 15 was upregulated following etoposide injection and irradiation. It is known that CDC2A/CCNB1 complex leads to the initiation of various steps necessary for mitosis [32] . In response to DNA damage, activity of the CDC2A/CCNB1 complex is suppressed by phosphorylation of CDC2A at tyrosine 15 and threonine 14, leading to blockage of G2/M progression [32] . Thus, our results suggest that cell cycle progression is arrested at the G2/ M border by etoposide injection and irradiation.
The requirement of TRP53 in G2/M arrest is controversial. Overexpression of TRP53 can induce G2/M arrest [47] , while some studies [48, 49] have reported that DNA damage-induced G2/M arrest is unaffected in Trp53-deficient cells. In a model of G2/M arrest, ataxia telangiectasia mutated (ATM), a DNA damage transducer, is activated following DNA double-strand breaks to phosphorylate CHEK2, and then phosphorylated CHEK2 leads to suppressive phosphorylation of CDC2A [18, 19] . According to this model, in which the function of the CDC2A/CCNB1 complex is suppressed in the absence of TRP53, activation of ATM would be an important event for TRP53-independent G2/M arrest in the present study. However, it is also known that the requirement of ATM in cell cycle arrest is dependent on the cellular differentiation status [50] or dose of irradiation [51] . Recently, it was reported that degradation of CCND1 and CCNE1 requires phosphorylation of specific residues in these proteins [52, 53] . Examining the phosphorylation state of cyclins would clarify the kinetics of cell cycle progression following DNA damage. Further studies are required to elucidate the molecular pathway of DNA damage-induced cell cycle arrest in the placenta.
Herein, we demonstrated that etoposide induced TRP53-dependent apoptosis in labyrinthine trophoblasts, which is consistent with previous studies [3] [4] [5] examining the effect of other DNA-damaging agents on the placenta. In contrast, etoposide-induced cell cycle arrest is elicited in a TRP53-independent manner. Disruption of the appropriate regulation of trophoblastic proliferation and apoptosis is considered to result in placental disorders [7, 8] . The present data will provide new insights into the molecular mechanisms of normal development and disorders of the placenta.
